These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2338279)

  • 1. Helicobacter associated gastritis in patients with duodenal ulcer: the influence of various drugs.
    Archimandritis AJ; Tjivras M; Davaris P; Alexiou A; Bitsikas J
    Gut; 1990 Apr; 31(4):481-2. PubMed ID: 2338279
    [No Abstract]   [Full Text] [Related]  

  • 2. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism.
    Levi S; Beardshall K; Swift I; Foulkes W; Playford R; Ghosh P; Calam J
    BMJ; 1989 Dec; 299(6714):1504-5. PubMed ID: 2514864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ulcer symptoms without demonstration of ulcer: causative therapy with demonstration of Helicobacter pylori].
    Kobler E; Müller B; Wüst W
    Schweiz Rundsch Med Prax; 1990 Mar; 79(13):398-9. PubMed ID: 2320815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Campylobacter pylori and treatment of duodenal ulcer].
    Zelenková J; Toman R; Bielaszewská M; Hanika J; Zeman V
    Vnitr Lek; 1990 Jun; 36(6):573-9. PubMed ID: 2219764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.
    Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C
    Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer.
    Biasco G; Miglioli M; Barbara L; Corinaldesi R; di Febo G
    Lancet; 1989 Dec; 2(8676):1403. PubMed ID: 2574352
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer.
    Winter TA; Louw JA; Marks IN; Jaskiewicz K; Lucke W; Callanan M
    Scand J Gastroenterol Suppl; 1995; 210():85-8. PubMed ID: 8578216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter pylori, duodenal ulcer disease, and gastrin.
    Levi S; Dollery CT; Bloom SR; Calam J; Cox TM; Hodgson HJ; Losowsky MS; Pepys MB; Wright NA; Wrong OM
    BMJ; 1989 Oct; 299(6707):1093-4. PubMed ID: 2511976
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.
    Lambert JR; McLean AJ
    Med J Aust; 1989 Aug; 151(3):120-2. PubMed ID: 2755371
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody titres to Campylobacter pylori after treatment for gastritis.
    Vaira D; Holton J; Cairns SR; Falzon M; Polydorou A; Dowsett JF; Salmon PR
    BMJ; 1988 Aug; 297(6645):397. PubMed ID: 3408982
    [No Abstract]   [Full Text] [Related]  

  • 12. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
    Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
    Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ulcer disease--drug treatment and its limitations].
    Arnold R
    Chirurg; 1990 Jan; 61(1):1-9. PubMed ID: 2107066
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 15. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
    Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
    Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month maintenance treatment of duodenal ulcer with sucralfate: influence on antral gastritis and Helicobacter pylori antral colonization--a prospective uncontrolled study.
    Archimandritis A; Tjivras M; Davaris P; Tryfonos M; Diamantis T; Nikolopoulou V; Katsakoulis E
    Clin Ther; 1993; 15(4):657-61. PubMed ID: 8221815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter pylori in upper digestive tract diseases in children.
    Celińska-Cedro D; Socha J; Teisseyre M
    Mater Med Pol; 1989; 21(4):259-62. PubMed ID: 2489238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori and bismuth subnitrate.
    Sodeman WA
    Am J Gastroenterol; 1990 Sep; 85(9):1200-1. PubMed ID: 2389738
    [No Abstract]   [Full Text] [Related]  

  • 20. Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection.
    Poynard T; Pignon JP; Mory B; Naveau S; Chaput JC
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):112B-115B. PubMed ID: 2663589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.